Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
International Journal of Molecular Sciences|November 13, 2021
Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative DisordersJana Mihályová, Katarína Hradská, Tomáš Jelínek, et al.
European Journal of Haematology|September 7, 2007
Monotherapy with low-dose thalidomide for relapsed or refractory multiple myeloma: better response rate with earlier treatmentVladimír Maisnar, Jakub Radocha, Tomás Büchler, et al.
Journal of Immunotoxicology|November 14, 2009
In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cellsFedor Kryukov, Darina Ocadlíková, Lucie Kovárová, et al.
Leukemia Research|April 14, 2009
Epigenetics of multiple myeloma after treatment with cytostatics and gamma radiationJana Krejcí, Andrea Harnicarová, Denisa Streitová, et al.
Blood Cancer Journal|December 3, 2024
Impact of T cell characteristics on CAR-T cell therapy in hematological malignanciesZhongfei Tao, Zuzana Chyra, Jana Kotulová, et al.
Acta Oncologica (Stockholm, Sweden)|September 4, 2012
Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven casesZdeněk Adam, Petr Szturz, Jiří Vaníček, et al.
Plos One|November 14, 2023
An economic evaluation of the effectiveness of telemedicine in hematooncologyMarian Lebiedzik, Kamila Turečkova, Ingrid Majerova, et al.
Biomarker Research|July 2, 2025
Novel immunotargets in multiple myeloma: biological relevance and therapeutic potentialJana Kotulová, Klára Baďurová, Zuzana Chyra, et al.
European Journal of Haematology|May 21, 2016
Activity of aldehyde dehydrogenase in B-cell and plasma cell subsets of monoclonal gammopathy patients and healthy donorsPavla Všianská, Renata Bezděková, Fedor Kryukov, et al.
Pageof 12